Riboflavin Transporter Deficiency (RTD) is a rare, life-shortening, neurodegenerative genetic disorder with onset occurring most often in childhood.  RTD was formerly known as Brown-Vialetto-Van Laere (BVVL) or Fazio-Londe (FL) syndrome.  First reported as an “infantile” form of ALS,  RTD affects motor and sensory nerve cells (neurons), taking away a person’s ability to hear, see, move, walk, eat and breathe.  RTD knows no ethnic boundaries and cases of RTD have been reported in every corner of the globe.  Despite the physically devastating effects of the disease, the mental capabilities of people with RTD remain completely intact. Daily treatment with riboflavin (vitamin B2) has recently shown great promise in slowing down the progression of RTD. More research is desperately needed to advance treatment, which will eventually lead to a cure for this devastating disease.

LATEST RESEARCH NEWS

Cure RTD Awards Phase 2 Research Grant to Dr. Steven Gray at UT Southwestern, Texas, USA for Gene Therapy Treatment for RTD

Cure RTD Awards Phase 2 Research Grant to Dr. Manoj Meneze, at the Children’s Hospital at Westmead (CHW) in Sydney, Australia

Cure RTD Supports Development of First Mouse Model of RTD Type 2

Cure RTD Awards Research Grant to Maria Barile, PhD, at University of Bari Aldo Moro in Italy

Cure RTD Awards Research Grant for Development of Clinical Outcome Measures, Australia

Cure RTD Awards Research Grant to Claudia Compagnucci, PhD, at the Bambino Gesù Children’s Research Hospital, Italy

Please take the time to watch this incredible short film about Hudson and his family. Hudson has Riboflavin Transporter Deficiency (RTD) Type 3. Hudson’s parents, Susie and Eric, talk about Hudson and the impact that RTD has had on the entire family. We hope you are inspired by this family’s hope, strength, and courage and help support Cure RTD’s mission to cure this dreadful disease.  You can watch this video on Cure RTD’s Youtube website at the following link:   Hudson’s RTD Journey